BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

The Diagnostic Odyssey in Myasthenia Gravis Patient #4: MuSK MG misdiagnosed as ALS

Activity Snapshot

Activity Type: 
Print/PDF
Release Date: 
Monday, April 11, 2022

Faculty

Ryan Ghusayni, MD
Duke University, Durham, North Carolina
Donal Sanders, MD
Duke University, Durham, North Carolina
Activity Overview: 

This case study will explore MuSK myasthenia gravis (MG) misdiagnosed as ALS in patient #4 (52-year-old-female).

Learning Objectives: 
  • Recognize clinical symptoms indicative of MG
  • Understand the optimal workflow for diagnosis based on clinical evaluation, detection of characteristic symptoms and physical findings, a detailed patient history, and a variety of specialized tests
  • Diagnose MG with increased skill and confidence, shortening the diagnostic journey of patients with MG
  • Understand how to optimize medical management of MG based on best practice guidelines